By Maia Szalavitz — 2012
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
Read on healthland.time.com
CLEAR ALL
Badass women making waves in the psychedelic movement, from research to drug policy reform.
1
Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.
The latest frontier in state and local drug reform has been the loosening of legal restrictions on psilocybin—the psychoactive compound in “magic mushrooms.”
Not long ago The New York Times carried a dispatch from Mexico telling about the descent of hippies on Huautla de Jimenez in quest of the “sacred mushrooms.” With the dispatch appeared a photo of a priestess of the rite, Maria Sabina.
The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.
My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.
2
Only a few days ago, millions of Americans probably had never heard of psilocybin, the active agent in psychedelic mushrooms, but thanks to Denver, it is about to get its moment in the political sun.
This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.
The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.